Prof. Dr. Mutlu Demiray is an innovative oncologist recognized for his pioneering approach to personalized treatment using molecular and genetic profiling. He has developed protocols for precision oncology and participated in international clinical research programs on immunotherapy. With over 20 years in practice, he combines scientific advancement with patient-specific care for optimal results. He regularly lectures on targeted therapy and translational oncology.
Author of 80+ papers including: – “Personalized molecular approach in lung cancer.” Clin Oncol, 2021 – “Advances in breast cancer targeted therapy.” Cancer Treat Rev, 2020 – “Immunotherapy pathways in gastrointestinal tumors.” Eur J Cancer, 2019
Сертифицировано и лицензировано: ISO 9001:2015 · ISO 10002:2018 · ISO 27001:2013 · ISO 14001 · ISO 45001 · TÜRSAB · Разрешение на медицинский туризм
